Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
Gastroenterology|October 31, 2020
Regeneration Defects in Yap and Taz Mutant Mouse Livers Are Caused by Bile Duct Disruption and CholestasisElisabeth Verboven, Iván M Moya, Leticia Sansores-Garcia, et al.
Cancer Cell|May 10, 2017
Hippo Signaling Suppresses Cell Ploidy and Tumorigenesis through Skp2Shihao Zhang, Qinghua Chen, Qingxu Liu, et al.
Nature Communications|February 20, 2015
Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesisHongtan Wu, Luyao Wei, Fuqin Fan, et al.
British Journal of Cancer|November 15, 2017
Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitorsJaffer A Ajani, Jeannelyn S Estrella, Qiongrong Chen, et al.
Nature Immunology|September 29, 2015
Kinases Mst1 and Mst2 positively regulate phagocytic induction of reactive oxygen species and bactericidal activityJing Geng, Xiufeng Sun, Ping Wang, et al.
Developmental Cell|February 13, 2019
FGF15 Activates Hippo Signaling to Suppress Bile Acid Metabolism and Liver TumorigenesisSuyuan Ji, Qingxu Liu, Shihao Zhang, et al.
Science (New York, N.Y.)|November 23, 2019
Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in miceIván M Moya, Stéphanie A Castaldo, Laura Van den Mooter, et al.
The Journal of Clinical Investigation|October 16, 2023
SPTAN1/NUMB axis senses cell density to restrain cell growth and oncogenesis through Hippo signalingDongxue Su, Yuxi Li, Weiji Zhang, et al.
Pageof 17